{
  "question": "In an inactive state, a transcription factor subunit awaits an activation signal from the membrane phosphorylation cascade. Upon phosphorylation on the Ser residues in the transactivation domain, it dimerizes, shuttles into the nucleus, and serves in gene transcription. A missense mutation X in the transactivation domain is a recessive loss-of-function mutation. You observe that a heterozygous mutation Y in the dimerization domain acts as a dominant-negative mutation. Which of the following molecular phenotypes is most likely observed in the presence of mutation Y?\n\nA) loss of protein dimerization and wild-type phenotype\nB) protein aggregation and loss-of-function phenotype\nC) protein degradation and loss-of-function of the wild-type allele\nD) change of protein conformation and gain-of-function phenotype\n\nOnce you feel you are ready for the final answer, directly return the answer with the format <<<answer content>>> at the end of your response, e.g. <<<C>>>, <<<A>>>",
  "response_list": [
    "A dominant-negative mutation creates a protein product that not only is non-functional itself but also interferes with the function of the wild-type protein produced from the normal allele. This phenomenon is particularly common for proteins that must assemble into multi-unit complexes, like dimers, to be active.\n\nHere is a breakdown of the scenario and options:\n\n*   **Normal Function:** Two wild-type (WT) subunits come together to form a functional WT-WT dimer, which then carries out transcription.\n*   **Mutation Y:** This is a heterozygous dominant-negative mutation in the dimerization domain. This means the cell produces both WT subunits and mutant (Y) subunits.\n*   **The Dominant-Negative Effect:** The Y subunit can still interact with WT subunits via the dimerization domain, even if that domain is faulty. This leads to the formation of WT-Y heterodimers. These heterodimers are non-functional because the mutation prevents the complex from working correctly. Additionally, any Y-Y homodimers that form are also non-functional.\n*   **The Outcome:** The presence of the Y subunit effectively \"poisons\" or sequesters the WT subunits into useless complexes, significantly reducing the amount of functional WT-WT dimers. This leads to an overall loss-of-function phenotype, even though the wild-type allele is present and producing a correct protein. The key mechanism is the interference by the mutant protein.\n\nAnalyzing the choices:\n\n*   **A) loss of protein dimerization and wild-type phenotype:** This is incorrect. A dominant-negative mutation results in a mutant phenotype, not a wild-type one.\n*   **B) protein aggregation and loss-of-function phenotype:** While protein aggregation can be a consequence of some mutations and cause a loss-of-function, it is not the most precise or universal mechanism for a dominant-negative mutation in a transcription factor. A mutation in a dimerization domain could lead to misfolding and aggregation, causing a loss-of-function phenotype.\n*   **C) protein degradation and loss-of-function of the wild-type allele:** The primary mechanism of a dominant-negative mutation is interference, not causing the degradation of the wild-type protein. The result is a functional loss for the wild-type allele, but the direct molecular action is not degradation.\n*   **D) change of protein conformation and gain-of-function phenotype:** This is incorrect. A dominant-negative effect is a type of loss-of-function, not a gain-of-function where the protein acquires a new, abnormal activity.\n\nRevisiting option B: Some mutations in dimerization domains can lead to misfolded proteins that form pathological aggregates, which is a specific mechanism of loss-of-function. However, the more general and defining characteristic of a dominant-negative mutation is interference with the wild-type protein. Of the choices provided, this option correctly identifies that the ultimate result is a loss-of-function phenotype. Given the context of a dimerization domain mutation, protein aggregation is a plausible molecular mechanism leading to this phenotype.\n\nComparing B and C, B presents a more plausible direct molecular mechanism (aggregation) than C (degradation of the wild-type allele). The term \"loss-of-function of the wild-type allele\" in option C is an outcome, not a mechanism, and protein degradation is not the typical mode of action. Protein aggregation as described in B is a valid molecular phenotype that can result from such a mutation and lead to a dominant-negative loss of function.\n\n<<<B>>>"
  ],
  "user_prompt_list": [
    "In an inactive state, a transcription factor subunit awaits an activation signal from the membrane phosphorylation cascade. Upon phosphorylation on the Ser residues in the transactivation domain, it dimerizes, shuttles into the nucleus, and serves in gene transcription. A missense mutation X in the transactivation domain is a recessive loss-of-function mutation. You observe that a heterozygous mutation Y in the dimerization domain acts as a dominant-negative mutation. Which of the following molecular phenotypes is most likely observed in the presence of mutation Y?\n\nA) loss of protein dimerization and wild-type phenotype\nB) protein aggregation and loss-of-function phenotype\nC) protein degradation and loss-of-function of the wild-type allele\nD) change of protein conformation and gain-of-function phenotype\n\nOnce you feel you are ready for the final answer, directly return the answer with the format <<<answer content>>> at the end of your response, e.g. <<<C>>>, <<<A>>>"
  ],
  "system_message": ""
}